Cover Image
市場調查報告書

歐洲的顯影劑及放射性醫藥品市場分析:2015年

Contrast Agents and Radiopharmaceuticals | Europe | 2015 | Market Analysis

出版商 Decision Resources Group - Medtech Solutions 商品編碼 339435
出版日期 內容資訊 英文 111 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的顯影劑及放射性醫藥品市場分析:2015年 Contrast Agents and Radiopharmaceuticals | Europe | 2015 | Market Analysis
出版日期: 2015年09月10日 內容資訊: 英文 111 Pages
簡介

償付法規嚴格以GBCA為中心的安全性相關討論持續中,歐洲的顯影劑及放射性醫藥品市場預計到2023年些微成長。這是因為放射性醫藥品的平均藥價提高,在歐洲的高齡化中診斷用影像治療的需求增加。

本報告提供歐洲的顯影劑及放射性醫藥品市場現狀與今後10年的預測,以及各分類市場的競爭趨勢、市場佔有率等彙整資料。

第1章 顯影劑及放射性醫藥品市場

  • 市場焦點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭焦點
  • 競爭環境
  • 市場佔有率
  • 市場因素與發展

第2章 放射性醫藥品

  • 市場焦點
  • 市場定義
  • 市場預測資料
    • SPECT
    • PET
  • 整體的市場趨勢
  • 競爭焦點
  • 競爭環境
  • 市場佔有率

第3章 CT及X光掃描顯影劑市場

  • 市場焦點
  • 市場定義
  • 市場預測資料
    • CT
    • 心血管用X光掃描
    • 一般X光掃描
  • 整體的市場趨勢
  • 競爭焦點
  • 市場佔有率

第4章 MRI顯影劑市場

  • 市場焦點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭焦點
  • 市場佔有率

第5章 超音波顯影劑市場

  • 市場焦點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭焦點
  • 市場佔有率

第6章 調查方法

第7章 簡稱、縮寫

第8章 參考文獻

圖表

目錄
Product Code: RPEU50RP15

Introduction:

Despite stringent reimbursement regulations and the ongoing safety controversy surrounding GBCAs, the European contrast agent and radiopharmaceutical market will exhibit slight growth through 2023, propelled by ASP hikes in the radiopharmaceutical space and the increasing demand for diagnostic imaging procedures for Europe's aging population.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe across a 10-year period.

Questions Answered in This Report:

  • Recent studies have questioned the safety of GBCAs.
    • How have European regulatory bodies and physicians responded to these studies?
    • To what extent will these studies impact the MRI contrast agent market through 2023?
    • How can competitors best respond to these safety concerns such that the impact on their products and revenues can be minimized?
  • Global fluctuations in the supply of Mo-99-the key isotope in the production of Tc for use in most SPECT procedures-will continue to negatively impact the market going forward.
    • To what extent will supply limitations affect revenue growth in the European SPECT radiopharmaceutical market?
    • What strategies will vendors and facilities employ in response to supply fluctuations?
  • Less contrast material is being used per patient procedure in Europe.
    • What are some of the key factors driving this trend?
    • Which markets will be the most impacted by this shift in usage?
  • The European market is highly competitive compared to the US market.
    • What are the key factors end users look for in a product?
    • How do local competitors fare compared to MNCs in the European contrast agent and radiopharmaceutical market?
    • How can smaller companies best position themselves to garner more market share going forward?

Table of Contents

  • Table of Contents
  • Tables and Figures
  • Executive Summary
  • Version History

1. Contrast Agent and Radiopharmaceutical Market

  • 1.1. Market Highlights
  • 1.2. Market Definitions
  • 1.3. Market Forecast Data
  • 1.4. General Market Trends
  • 1.5. Competitive Highlights
  • 1.6. Competitive Landscape
  • 1.7. Market Shares
  • 1.8. Market Factors and Developments

2. Radiopharmaceutical Market

  • 2.1. Market Highlights
  • 2.2. Market Definitions
  • 2.3. Market Forecast Data
    • 2.3.1. SPECT Radiopharmaceuticals
    • 2.3.2. PET Radiopharmaceuticals
  • 2.4. General Market Trends
  • 2.5. Competitive Highlights
  • 2.6. Competitive Landscape
  • 2.7. Market Shares

3. CT and X-Ray Contrast Agent Market

  • 3.1. Market Highlights
  • 3.2. Market Definitions
  • 3.3. Market Forecast Data
    • 3.3.1. CT
    • 3.3.2. Cardiovascular X-Ray
    • 3.3.3. Conventional X-Ray
  • 3.4. General Market Trends
  • 3.5. Competitive Highlights
  • 3.6. Market Shares

4. MRI Contrast Agent Market

  • 4.1. Market Highlights
  • 4.2. Market Definitions
  • 4.3. Market Forecast Data
  • 4.4. General Market Trends
  • 4.5. Competitive Highlights
  • 4.6. Market Shares

5. Ultrasound Contrast Agent Market

  • 5.1. Market Highlights
  • 5.2. Market Definitions
  • 5.3. Market Forecast Data
  • 5.4. General Market Trends
  • 5.5. Competitive Highlights
  • 5.6. Market Share Rankings

Appendix: Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Table 1: Contrast Agent and Radiopharmaceutical Market Landscape, Europe (USD), 2014 and 2023
  • Table 2: Contrast Agent and Radiopharmaceutical Procedure Market Share Rankings, by Product Type, Europe, 2014
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
  • Table 5: Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
  • Table 6: Geographies Covered, Europe
  • Table 7: Average Currency Exchange Rates
  • Table 8: Contrast Agents and Radiopharmaceuticals Covered, Europe
  • Table 9: Version History
  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Figure 3: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 10: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Table 11: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (EUR and GBP), 2013--2023
  • Table 12: Contrast Agent and Radiopharmaceutical Market Growth, by Product Type, Europe, 2014--2023
  • Table 13: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 14: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 15: Contrast Agent and Radiopharmaceutical Market Growth, by Country, Europe, 2014--2023
  • Figure 4: Contrast Agent and Radiopharmaceutical Procedure Market Shares, Europe, 2014
  • Table 16: Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2014
  • Table 17: Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Product Type, Europe, 2014
  • Table 18: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
  • Table 19: Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
  • Figure 5: Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Figure 6: Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 20: Radiopharmaceutical Market, by Product Type, Europe (USD), 2013--2023
  • Table 21: Radiopharmaceutical Market, by Product Type, Europe (EUR and GBP), 2013--2023
  • Table 22: Radiopharmaceutical Market Growth, by Product Type, Europe, 2014-- 2023
  • Table 23: Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 24: Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2013-- 2023
  • Table 25: Radiopharmaceutical Market Growth, by Country, Europe, 2014--2023
  • Table 26: Nuclear Medicine System Installed Base, by Product Type, Europe, 2013-- 2023
  • Table 27: Nuclear Medicine System Installed Base, by Country, Europe, 2013--2023
  • Table 28: SPECT Radiopharmaceutical Market, by Country, Europe (USD), 2013-- 2023
  • Table 29: SPECT Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 30: SPECT Radiopharmaceutical Market Growth, by Country, Europe, 2014-- 2023
  • Table 31: SPECT Radiopharmaceutical Installed Base, by Country, Europe, 2013-- 2023
  • Table 32: PET Radiopharmaceutical Market, by Country, Europe (USD), 2013--2023
  • Table 33: PET Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 34: PET Radiopharmaceutical Market Growth, by Country, Europe, 2014--2023
  • Table 35: PET Radiopharmaceutical Installed Base, by Country, Europe, 2013--2023
  • Figure 7: SPECT Radiopharmaceutical Procedure Market Shares, Europe, 2014
  • Table 36: SPECT Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2014
  • Figure 8: CT and X--Ray Contrast Agent Market, by Product Type, Europe (USD), 2013--2023
  • Figure 9: CT and X--Ray Contrast Agent Market, by Country, Europe (USD), 2013-- 2023
  • Table 37: CT and X--Ray Contrast Agent Market, by Product Type, Europe (USD), 2013--2023
  • Table 38: CT and X--Ray Contrast Agent Market, by Product Type, Europe (EUR and GBP), 2013--2023
  • Table 39: CT and X--Ray Contrast Agent Market Growth, by Product Type, Europe, 2014--2023
  • Table 40: CT and X--Ray Contrast Agent Market, by Country, Europe (USD), 2013-- 2023
  • Table 41: CT and X--Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 42: CT and X--Ray Contrast Agent Market Growth, by Country, Europe, 2014-- 2023
  • Table 43: CT and X--Ray System Installed Base, by Country, Europe, 2013--2023
  • Table 44: CT System Installed Base, by Country, Europe, 2013--2023
  • Table 45: X--Ray System Installed Base, by Country, Europe, 2013--2023
  • Table 46: CT Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 47: CT Contrast Agent Market, by Country, Europe (EUR and GBP), 2013-- 2023
  • Table 48: CT Contrast Agent Market Growth, by Country, Europe, 2014--2023
  • Table 49: Cardiovascular X--Ray Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 50: Cardiovascular X--Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 51: Cardiovascular X--Ray Contrast Agent Market Growth, by Country, Europe, 2014--2023
  • Table 52: Conventional X--Ray Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 53: Conventional X--Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 54: Conventional X--Ray Contrast Agent Market Growth, by Country, Europe, 2014--2023
  • Figure 10: CT and X--Ray Contrast Agent Procedure Market Shares, Europe, 2014
  • Table 55: CT and X--Ray Contrast Agent Procedure Market Shares, by Country, Europe, 2014
  • Figure 11: MRI Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 56: MRI Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 57: MRI Contrast Agent Market, by Country, Europe (EUR and GBP), 2013-- 2023
  • Table 58: MRI Contrast Agent Market Growth, by Country, Europe, 2014--2023
  • Table 59: MRI System Installed Base, by Country, Europe, 2013--2023
  • Figure 12: MRI Contrast Agent Procedure Market Shares, Europe, 2014
  • Table 60: MRI Contrast Agent Procedure Market Shares, by Country, Europe, 2014
  • Figure 13: Ultrasound Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 61: Ultrasound Contrast Agent Market, by Country, Europe (USD), 2013--2023
  • Table 62: Ultrasound Contrast Agent Market, by Country, Europe (EUR and GBP), 2013--2023
  • Table 63: Ultrasound Contrast Agent Market Growth, by Country, Europe, 2014-- 2023
  • Table 64: Ultrasound Contrast Agent Revenue Market Share Rankings, Europe, 2014
  • Table 65: Acronyms and Initialisms
Back to Top